Ivana Rakitovac
About Ivana Rakitovac
Ivana Rakitovac is a Cell Therapy Specialist at Kite Pharma in Hoofddorp, Netherlands, with a diverse educational background in BioPharmaChem and Telematics. She has experience in various roles, including manufacturing and volunteering, and is committed to continuous learning in pharmaceutical technology.
Work at Kite Pharma
Ivana Rakitovac has been employed at Kite Pharma as a Cell Therapy Specialist since 2020. She works in Hoofddorp, North Holland, Netherlands. In this role, she contributes to the development and implementation of cell therapy solutions, leveraging her expertise in the biopharmaceutical field. Kite Pharma focuses on innovative cancer therapies, and Rakitovac's position is integral to advancing the company's mission.
Education and Expertise
Rakitovac holds a Bachelor's degree in Telematics from Veleučilište u Rijeci / Polytechnic of Rijeka, which she completed from 2010 to 2015. She furthered her education by obtaining a Bachelor's degree in BioPharmaceutical and Medical Device Manufacturing from Technological University Dublin in 2020. Additionally, she studied BioPharmaChem at the Dublin Institute of Technology, achieving CPD from 2018 to 2019. Her educational background supports her role in cell therapy and biopharmaceutical technology.
Background
Ivana Rakitovac has a diverse professional background that includes experience in technical design, programming, databases, and technical writing. Prior to her role at Kite Pharma, she worked as a Manufacturing Operator at Mylan from 2018 to 2020 in County Dublin, Ireland. Rakitovac has also engaged in various roles such as court volunteering, sales support, warehouse work, and assisting older and disabled individuals. Her adaptability is highlighted by her move to a new country alone.
Professional Development
Rakitovac is open to learning from others and seeks to expand her knowledge through shared experiences. She is actively exploring the field of pharmaceutical technology, indicating her commitment to professional growth and adaptation to new industry trends. This proactive approach to learning enhances her capabilities as a Cell Therapy Specialist and contributes to her effectiveness in the biopharmaceutical sector.